Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pinggan Huoxue is a Traditional Chinese Medicine (TCM) formulation administered via acupoint application (transdermal patch) for the treatment of hypertension. Developed by researchers at Guang'anmen Hospital of the China Academy of Chinese Medical Sciences, the therapy is designed according to the TCM principles of "calming the liver" (Pinggan) and "promoting blood circulation" (Huoxue). The formulation is typically applied to specific acupuncture points to allow for the transdermal absorption of active herbal constituents, aiming to regulate blood pressure and alleviate symptoms associated with liver hyperactivity and blood stasis. It is primarily being investigated for its efficacy in managing Grade 1 hypertension as a non-invasive adjunct to lifestyle interventions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pinggan Huoxue.